Drugs / CD276 CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05143151 | Jul 2021 → Jun 2024 | — | Shenzhen University General Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD276 CAR-T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05143151 ↗ |
| Modality | Cell therapy | “CD276 targeted chimeric antigen receptor cells treatment” NCT05143151 ↗ |
| Target | CD276 | “CD276 targeted chimeric antigen receptor cells treatment” NCT05143151 ↗ |